NM_022089.4:c.3176T>G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_022089.4(ATP13A2):c.3176T>G(p.Leu1059Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1059F) has been classified as Uncertain significance.
Frequency
Consequence
NM_022089.4 missense
Scores
Clinical Significance
Conservation
Publications
- Kufor-Rakeb syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, G2P, ClinGen
- autosomal recessive spastic paraplegia type 78Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- parkinsonism due to ATP13A2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022089.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP13A2 | NM_022089.4 | MANE Select | c.3176T>G | p.Leu1059Arg | missense | Exon 27 of 29 | NP_071372.1 | ||
| ATP13A2 | NM_001141973.3 | c.3161T>G | p.Leu1054Arg | missense | Exon 27 of 29 | NP_001135445.1 | |||
| ATP13A2 | NM_001141974.3 | c.3044T>G | p.Leu1015Arg | missense | Exon 26 of 27 | NP_001135446.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP13A2 | ENST00000326735.13 | TSL:1 MANE Select | c.3176T>G | p.Leu1059Arg | missense | Exon 27 of 29 | ENSP00000327214.8 | ||
| ATP13A2 | ENST00000452699.5 | TSL:1 | c.3161T>G | p.Leu1054Arg | missense | Exon 27 of 29 | ENSP00000413307.1 | ||
| ATP13A2 | ENST00000341676.9 | TSL:1 | c.3044T>G | p.Leu1015Arg | missense | Exon 26 of 27 | ENSP00000341115.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 69
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The p.L1059R variant (also known as c.3176T>G), located in coding exon 27 of the ATP13A2 gene, results from a T to G substitution at nucleotide position 3176. The leucine at codon 1059 is replaced by arginine, an amino acid with dissimilar properties. This variant has been observed in trans with a frameshift mutation in two siblings with Kufor-Rakeb syndrome (KRS) and was observed to results in mislocalization of the ATP13A2 protein (Park JS et al. Hum. Mutat., 2011 Aug;32:956-64). This amino acid position is highly conserved through mammals but not in all available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at